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ABSTRACT
The etiology and pathogenesis of Kawasaki disease (KD) remain poorly understood. Among the diverse infectious and environmental 
factors examined to be triggers for, or be associated with, KD, are immunizations. We are reporting a case of refractory Kawasaki 
disease after DPT booster in a 5-year-old male child, who responded after two doses of IVIG and a course of IV Methylprednisolone. 
Prior published case reports and large epidemiological studies, which explore potential associations between immunization and KD, 
are also comprehensively reviewed.
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Kawasaki disease (KD) is an acute, multisystem vasculitis, characterized by a combination of symptoms, including fever for > 5days, rash, conjunctival injection with 
limbal sparing, unilateral cervical lymphadenopathy of more 
than or equal to 1.5 cm, oral mucosal changes and characteristic 
extremity changes. The etiology of KD is not clear but certain 
epidemiologic and clinical features support an infectious origin. 
These features include the young age group, self-limited nature 
of acute febrile illness and the clinical features of fever, rash, 
exanthem, conjunctival injection and cervical lymphadenopathy. 
However, there are features that are not consistent with an 
infectious origin such as multiple members within the same 
family being affected at the same time. Furthermore, no single 
infectious etiologic agent has been successfully identified despite 
a comprehensive search [1].  
In addition, data indicate that host genetics underlie the 
disease’s pathogenesis.  Few cases of occurrence of KD after 
vaccination have been reported but no causal relationship has been 
established [2,3]. Histologically, coronary arteritis begins 6-8 days 
after the onset of KD, and leads immediately to inflammation of all 
layers of the artery. The inflammation spreads completely around 
the artery; as a result, structural components of the artery undergo 
intense damage; the artery then begins to dilate. Inflammatory cell 
infiltration continues until about the 25th day of the disease, after 
which the inflammatory cells gradually decrease in number.
KD arteritis is characterized by granulomatous inflammation 
that consists of a severe accumulation of monocytes/macrophages. 
Aberrant activation of monocytes/macrophages is thought to be 
involved in the formation of vascular lesions. The lesions in all the 
arteries are relatively synchronous as they evolve from acute to 
chronic injury [4]. We herein report the case of a 5-year-old male 
child, who developed KD two days after receiving Diphtheria, 
Pertussis, and Tetanus (DPT) booster and was managed with two 
courses of Intravenous immunoglobulin (IVIg) and a course of 
intravenous (IV) methylprednisolone.
CASE REPORT
A 5-year-old male child presented with complaints of fever, 
headache, pain in the neck and vomiting for two days. He was 
vaccinated for DPT booster two days ago. There was no history of 
cough, cold, loose stools, urinary complaints or rashes. Past and 
family history was also not significant. 
On examination, he was febrile, sick looking and vitals were 
stable. Multiple right cervical lymph nodes were tender, palpable 
and were measuring 2cmx2cm. Cardiovascular, neurological and 
respiratory system examinations were normal. On abdominal 
examination, mild distension, 1.5 cm soft liver with a smooth 
surface and the regular margin was palpable below the right 
costal margin. There was no splenomegaly, no free fluid and 
bowel sounds were normal. 
Investigations revealed erythrocyte sedimentation rate (ESR)-
29 mm, C-reactive protein (CRP) - 10 mg/dl, total leucocyte count 
(TLC) - 16600/mm3 with 85% neutrophils, and 13% lymphocytes. 
Platelet count was 340,000/mm3, and there was mild transaminitis 
(Serum glutamic oxaloacetic transaminase (SGOT) - 117U/dl, 
Serum glutamic pyruvic transaminase (SGPT) -120 U/dl) and 
hyponatremia (126 mg/dl). 
A provisional diagnosis of acute febrile illness was kept and 
the child was started on IV antibiotics in view of neutrophilia and 
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raised CRP. On day 5 of fever, red strawberry tongue, conjunctival 
redness and a maculopapular rash over the back were noticed. 
Diagnosis of Kawasaki disease was considered and IVIG was 
given at a dose of 2 g/kg over two days. Aspirin was started at a 
dose of 80mg/kg/day in four divided doses. 
Echocardiography done at this stage was normal. Reports 
of blood culture, urine culture, typhi dot, dengue serology, 
chikungunya serology, leptospira serology, Weil-Felix reaction 
and tubercular work-up were negative. Antibiotics were stopped. 
Ultrasonography (USG) neck revealed multiple necrotic lymph 
nodes. Fine needle aspiration cytology (FNAC) of the right cervical 
lymph node revealed reactive lymphoid cells with occasional 
plasma cells and histiocytes. Magnetic resonance imaging (MRI) 
brain revealed a hyperintense signal with restricted diffusion in 
the splenium of corpus callosum suggestive of post-vaccination 
encephalitis or post-infective ischemic changes. However, there 
were no clinical signs suggestive of encephalitis. 
Fever was persistent although with decreased spikes (up to 
101.60 F) on day11 of illness. CRP (6.4 mg/dl), ESR (40 mm) 
and platelet count (520,000/mm3) were still raised even after 36 
hours of initial IVIG infusion. A repeat dose of IVIG (2g/kg) was 
administered over two days. The child responded to the second 
dose of IVIG as fever resolved but CRP (2.2 mg/dl) and ESR 
(18 mm) were still raised and platelet count (634,000/mm3) was 
on increasing trend after another 48 hours. However, there was a 
repeat fever spike, so IV Methylprednisolone was given at a dose 
of 30 mg/kg/day for three days followed by oral prednisolone at a 
dose of 1 mg/kg/day for one week and then tapered over the next 
week to prevent a recurrence. Aspirin was reduced to 3mg/kg/day 
and was given for 8 weeks. 
Coronary findings were normal throughout the course. 
Inflammatory markers (CRP 0.8 mg/dl, ESR 6 mm, platelet 
count 360,000/mm3) normalized within 48 hours after IV 
methylprednisolone infusion and repeat echocardiography at 
two weeks was also normal. Follow-up echocardiography and 
inflammatory markers (CRP 0.5 mg/dl, ESR 4 mm, platelet count 
300,000/mm3) at six weeks and three months were also normal. 
This entire event following DPT vaccination was reported to the 
adverse drug reaction (ADR) system.
DISCUSSION
Incidence of KD in Japan, Taiwan and Germany are 264.8/lakh, 
55.9/lakh and 7.2/lakh respectively. Incidence of IVIG resistance 
in Japan, Taiwan and Germany is 17%, 12.5% and 26.8%, 
respectively [5]. Although we do not have any countrywide 
epidemiologic data for India reports strongly suggest that the 
incidence of KD is showing an upward trend. For instance, 
extrapolations from the hospital-based registry at Chandigarh 
showed that the incidence of KD had increased from 0.51 to 
4.54/100,000 children aged below 15 years during the period 
1994- 2007 [6].  
Common side effects following DPT vaccination are local 
pain, swelling and fever [7]. Cases of KD are reported after 
rotavirus and pentavalent (DTaP-IPV-HiB) and pneumococcal 
(PCV 13) vaccination [3]. Ece I et al [3] described a case of KD 
in a 2-month-old infant who developed KD 1 day after receiving 
his first dose of conjugate vaccine (DTaP-IPV-Hib) and PCV13. 
Yin Set al. [8] described a 20-month-old child who developed 
KD after receiving her second dose of Lanzhou lamb rotavirus 
vaccine (LLR) and her first dose of freeze-dried live attenuated 
hepatitis A vaccine. Shaikh S et al [9], Talebian A et al [10], and 
Leonardi S et al [11] have described the cases of refractory KD 
post-vaccination, who responded after 2 doses of IVIG and IV 
methylprednisolone.
Central nervous system (CNS) lesions may occur and despite 
their severity, as shown in a number of case reports in the literature 
[12], they are mostly self-limited findings, whose clearing could 
take months, but could also leave sequelae, such as brain atrophy, 
ischemic lesions, including cognitive and behavioral conditions 
[13]. Meningoencephalitides, subdural effusions, hypoperfused 
brain, and ischemia, cerebral and cerebellar infarction are 
CNS changes also being frequently detected from better KD 
recognition and from a more extended follow-up in these patients. 
CNS lesions should always be considered in KD, mainly in severe 
cases with high and extended inflammatory activity and the 
presence of a coronary impairment with or without neurological 
manifestations. 
This was a 5-year-old male child who developed fever two 
days after DPT vaccination and other features of KD by 5th day of 
fever. To the best of our knowledge, no such case of KD has been 
reported after DPT vaccination alone in the literature till now. In 
our case, in the absence of any infectious etiology and presence of 
persistent fever, rash, conjunctivitis, strawberry tongue, cervical 
lymphadenopathy and increased levels of acute-phase reactants 
(ESR, CRP and platelets) clinched the diagnosis of KD. The child 
responded partially to the first dose of IVIG, so repeat dose of 
IVIG was given. In view of persistently elevated acute phase 
reactants and recurrence of fever, IV Methylprednisolone was 
given followed by oral steroids for 2 weeks. 
According to a study, in cases of KD unresponsive to an 
additional infusion of IVIG, IV methylprednisolone therapy-
induced prompt defervescence and subsequent treatment with 
oral prednisolone suppressed recurrent fever [14]. Follow-up 
protocol of Kawasaki disease includes ECHO at diagnosis, at 2 
weeks and 6 - 8 weeks later. Repeat echocardiogram beyond 8 
weeks in patients with previously normal findings is considered 
optional. Cardiological risk assessment and counseling is 
advised every 5 years. For patients with coronary abnormalities, 
the frequency of cardiology follow-up visits is more. Overall 
DPT vaccination is very safe. KD may be a rare side effect of 
vaccination.  Kawasaki disease (KD) is one of the most common 
vasculitides of childhood. Previous investigations into vasculitis 
and KD have reported them as side effects of various vaccinations 
[15-16].
CONCLUSION
Our case highlights the possible association of KD with DPT and 
the fact that there is a chance of no response to IVIG even after 
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36 hours of therapy; thus mandating a second dose of IVIG and 
IV methylprednisolone. Refractory cases of KD have never been 
reported post-DPT vaccines.
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